Skip to content

High long-term economic costs associated with late HIV diagnosis

Lymphocyte count and haemoglobin can predict prognosis of patients starting ART

Image: phloxii/Shutterstock.com

Neurocognitive impairment linked to prior low CD4 cell count, even if on current suppressive HIV treatment

CASCADE analysis finds antiretroviral treatment benefits are evident below CD4 count of 500, uncertain above this level

Lopinavir/ritonavir plus raltegravir NRTI-sparing regimen as effective as traditional HAART

Newer HIV drugs cost-effective for Africa

Starting HIV treatment improves immune response to Kaposi's sarcoma

Start HIV treatment earlier to reduce risk of hardening of the arteries

START… and why the time is now